Paraneoplastic syndromes (PNS) are neoplasm-associated alterations in bodily structure and/or function that occur distant to the tumor. They are an extremely diverse group of clinical aberrations that are associated with the non-invasive actions of the tumor.
Paraneoplastic syndromes (PNS) are neoplasm-associated alterations in bodily structure and/or function that occur distant to the tumor. They are an extremely diverse group of clinical aberrations that are associated with the non-invasive actions of the tumor.
Mammary gland tumors (MGT) are some of the most common tumors seen in veterinary clinical practice. They are the most common tumor seen in the female dog and the second most common tumor of the female cat.
Osteosarcoma (OSA) is the most common primary bone tumor in the dog (85% of skeletal malignancies). It is estimated to occur in over 8,000 dogs/year in the United States.
Head and neck tumors are relatively common in cats. An understanding of the differentials in this anatomic location is very important as the diagnostic and therapeutic approach may vary.
Lymphoma (LSA) is the most common tumor of the cat and represents approximately 80-90% of hematopoietic tumors in cats. LSA is the third most common tumor in the dog with an estimated annual incidence of 13-24/100,000 dogs at risk.
Mast cell tumors (MCT's) are the most common tumor in the dog and the second most common tumor in the cat. MCT's are primarily a disease of older dogs and cats, however, extremely young dogs and cats have been reported to have MCT's.
Vaccination has generally been considered to be a benign procedure in veterinary medicine. Unfortunately, soft tissue sarcoma development subsequent to vaccination (vaccine-associated sarcoma; VAS) in cats has dramatically changed this view within our profession over the last twenty years.
Canine malignant melanoma (CMM) of the oral cavity, nail bed, foot pad and mucocutaneous junction is a spontaneously occurring, highly aggressive and frequently metastatic neoplasm. CMM is a relatively common diagnosis representing ~ 4% of all canine tumors and it is the most common oral tumor in the dog.
The recognition of the development of potentially malignant tumors arising from injection sites became one of the most significant events in veterinary medicine in the 1980's and beyond. So significant, in fact, that it caused an entire profession to re-evaluate the way preventative medicine should be considered from a medical and an economic perspective.
In this online on-demand course, Dr. Pam Jones will discuss thoracic cavity cancers, including emergency case management and treatment options for chest cavity tumors including chemotherapy and surgery. (1 CE credit)
This online on-demand course discusses chemotherapy administration and the potential complications associated with its administration. (1 CE credit)
This online on-demand course emphasizes the importance of immunohistochemistry and understanding the different histologic subtypes of lymphoma. (1 CE credit)
Denver/Overland Park, Kan. -- A three-year, $1 million project seeking to prevent, treat and cure cancer in dogs.
Phoenix, Ariz. -- The Translational Genomics Research Institute (TGEN) and the Van Andel Research Institute (VAI) have created a new Canine Hereditary Cancer Consortium, which aims to study naturally occurring cancers in dogs to better understand how the disease develops in both animals and humans.
West Lafayette, Ind. - Old dogs may be able to teach veterinary researchers new tricks about cancer and aging.
Mammary gland tumors remain one of the most common cancers in our canine patients.
A 9-year-old spayed female golden retriever was presented to the Tufts Veterinary Emergency Treatment and Specialties hospital for evaluation of a perianal mass.
Lymphoma (LSA) is one of the most common feline malignancies, comprising approximately 30% of all reported tumors. While not curable, LSA may respond quite well to therapy and can be a very satisfying neoplasm to treat.
One of the most common questions an oncologist hears from a pet owner is, "Why did my dog get cancer?" While it is often impossible to provide a specific answer for a specific patient, our understanding of why cancer develops has grown exponentially in the past decade. As are most things in the living organism, the causes are extremely complex, multifactorial, and still not completely understood.
Osteosarcoma (OSA) and hemangiosarcoma (HSA) are highly malignant tumors that have both a locally invasive and highly metastatic biologic behavior. Multimodality therapy must be employed to provide patients with these cancers the best chance for improved quality and quantity of life.
Cytology is a critical tool not only for the oncologist, but also for veterinarians in general practice. Cytology is easy, safe, fast, relatively inexpensive, and is often diagnostic.
Canine lymphoma (LSA) makes up approximately 18% of all malignancies in the dog, and 80% of all hematopoietic tumors in dogs are LSA. Middle-aged dogs are most commonly affected; but out of cancers affecting young dogs (as young as 6 months), LSA is common.
Speaking with pet owners is something veterinarians do constantly; as such, it is the most common "procedure" performed in veterinary medicine. Yet very few veterinarians receive any guidance in this critical area during veterinary school or after.
Chemotherapy safety can be broken down into two big categories: safety for the patient, and safety for the individuals handling the drugs. Understanding how chemotherapy works provides a background for knowing potential dangers of treatments as well as how to safely use these beneficial drugs.
